Intrathecal pumps, once considered a niche medical solution, are now at the forefront of pain management technologies. Designed to deliver medication directly to the spinal cord, these implantable ...

Zolgensma as an intravenous infusion has been approved in the U.S. for children under 2 years with SMA since 2019. The intrathecal version injects the gene therapy directly into the spinal cord ...